Siemens Healthineers and University of Miami Health System Enter Value Partnership Agreement to Transform Healthcare

Siemens HealthineersSiemens Healthineers and UHealth - University of Miami Health System - announced a Value Partnership(1) agreement. This strategic relationship will further technological advancement and standardization of equipment at the health system, while allowing the university to create educational and training programs for clinicians and technologists. This unique agreement is the first of its kind in Florida.

Through this planned ten-year agreement, UHealth will acquire the latest medical technology equipment from both Siemens Healthineers and Varian, a Siemens Healthineers company, which will help expand diagnostic and therapeutic treatments. Other aspects of the Value Partnership include educational and service offerings, digital health technology and consulting services.

Also, through the collaboration, new clinical and operational strategies will be developed and deployed to evolve care, enhance diagnosis, and improve the overall health of Floridians.

"Building new clinical structures over the next few years, our goal is to incorporate the latest technological advances to serve our patients," said Alexander McKinney, M.D., chair of the Department of Radiology at the University of Miami Health System. "We look forward to working with the team at Siemens Healthineers."

In conjunction with adding world-class medical technology equipment at UHealth's various locations throughout Florida, technology from Siemens Healthineers will be used in training the next generation of physicians.

"Our equipment and solutions will be a great addition to the University of Miami Health System's already rapidly expanding footprint, allowing it to expand its educational and training offerings across the region," said David Pacitti, president and head of the Americas, Siemens Healthineers. "This Value Partnership is a proof point of the unbroken, strong demand for Siemens Healthineers’ products, services and solutions in the North American market."

Financial terms were not disclosed.

Through the "Value Partnership" partnership model, hospitals can optimize business processes, expand capabilities and drive innovation. These partnerships rely on the entire Siemens Healthineers portfolio to create added value beyond equipment.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion.

1. Value Partnership is a branded enterprise service offering from Siemens Healthineers. The term "Value Partnership" does not imply, create, and/or establish a legal partnership or joint venture between Siemens Healthineers and the University of Miami Health System.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...